[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@AppleHelix Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::98707539.png) @AppleHelix Jing Liang 🇺🇦

Jing Liang 🇺🇦 posts on X about $nvo, $ww, $lly, $prax the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::98707539/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:interactions.svg)

- X Week XXXXXX -XXXX%
- X Month XXXXXX -XXXX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX +2.20%

### Mentions: X [#](/creator/twitter::98707539/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:posts_active.svg)

- X Week XX no change
- X Month XX +32%
- X Months XXX +17%
- X Year XXX +14%

### Followers: XXXXXX [#](/creator/twitter::98707539/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:followers.svg)

- X Week XXXXXX +0.44%
- X Month XXXXXX +1.30%
- X Months XXXXXX +8.50%
- X Year XXXXXX +18%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::98707539/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::98707539/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX%

**Social topic influence**
[$nvo](/topic/$nvo) 3.13%, [$ww](/topic/$ww) 3.13%, [$lly](/topic/$lly) 3.13%, [$prax](/topic/$prax) 3.13%, [bless](/topic/bless) 3.13%, [has been](/topic/has-been) 3.13%, [build a](/topic/build-a) 3.13%, [a very](/topic/a-very) 3.13%, [$abvx](/topic/$abvx) 3.13%, [uc](/topic/uc) XXXX%

**Top accounts mentioned or mentioned by**
[@sharkbiotech](/creator/undefined) [@jacobplieth](/creator/undefined) [@bambossie81](/creator/undefined) [@houndcl](/creator/undefined) [@biopharmiq](/creator/undefined) [@dickmedchem](/creator/undefined) [@dtrmweihe](/creator/undefined) [@thebiohunter](/creator/undefined) [@realrambogotier](/creator/undefined) [@gcbioinv](/creator/undefined) [@lauraloomer](/creator/undefined) [@bigpharmaguy](/creator/undefined) [@tcellengager](/creator/undefined) [@aditharun](/creator/undefined) [@jq1234t](/creator/undefined) [@savoryseaw50174](/creator/undefined) [@adar170](/creator/undefined) [@snupsnus](/creator/undefined) [@oncologytube](/creator/undefined) [@bin2gray](/creator/undefined)

**Top assets mentioned**
[Novo-Nordisk (NVO)](/topic/$nvo) [WW International, Inc. Common Stock (WW)](/topic/$ww) [Eli Lilly and Company (LLY)](/topic/$lly) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax)
### Top Social Posts [#](/creator/twitter::98707539/posts)
---
Top posts by engagements in the last XX hours

"It seems prescription Rx is going towards the DTC model bypassing PBMs (TrumpRx). If I were $NVO or $LLY I would consider buying $WW as a distribution channel"  
[X Link](https://x.com/AppleHelix/status/1978113648145883435) [@AppleHelix](/creator/x/AppleHelix) 2025-10-14T15:00Z 10.1K followers, 3057 engagements


"1/ A few couple thoughts on $PRAX. - I love randomized withdrawal trials. Wish they are done more often. - FDA seems to bless these X studies as pivotal based on June 2023 PR - Pre-NDA request filed meaning $PRAX may get feedback by JP Morgan"  
[X Link](https://x.com/AppleHelix/status/1978789822069166479) [@AppleHelix](/creator/x/AppleHelix) 2025-10-16T11:47Z 10.1K followers, 27.5K engagements


"Bertrand raises a very good point. Can one build a large European biotech without US investors Argenx and Ablynx come to mind. But they still had some US investors in the syndicate(s)"  
[X Link](https://x.com/AppleHelix/status/1947990259255373936) [@AppleHelix](/creator/x/AppleHelix) 2025-07-23T12:00Z 10.1K followers, 3643 engagements


"Must read article. H/T @jq1234t Imputation methodology is super important This is rarely discussed during clinical trial design"  
[X Link](https://x.com/AppleHelix/status/1979569451214438763) [@AppleHelix](/creator/x/AppleHelix) 2025-10-18T15:25Z 10.1K followers, 1588 engagements